BNP Paribas Financial Markets
VTYX

BNP Paribas Financial Markets’s Ventyx Biosciences VTYX Stock Holding History

BNP Paribas Financial Markets’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-452,310
Closed -$4.08M – 6152
2025
Q4 		$4.08M Buy
452,310
+452,069
+187,580% +$3.38M ﹤0.01% 2177
2025
Q3 		$750 Sell
241
-13,979
-98% -$37K ﹤0.01% 5263
2025
Q2 		$30.4K Sell
14,220
-120,390
-89% -$194K ﹤0.01% 4438
2025
Q1 		$155K Buy
134,610
+8,467
+7% +$14.5K ﹤0.01% 3852
2024
Q4 		$276K Buy
+126,143
New +$286K ﹤0.01% 3687

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's VTYX Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 452,310 shares — an estimated $4.08M sold.

BNP Paribas Financial Markets first reported a position in VTYX in Q4 2024 and held it in 5 quarters. The position peaked at $4.08M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 452,310 Ventyx Biosciences shares in Q1 2026, an estimated $4.08M.
  • BNP Paribas Financial Markets first reported a position in Ventyx Biosciences in Q4 2024 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Ventyx Biosciences position peaked at $4.08M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.